NCT03938324 2025-07-28
PiCASO
Duke University
Phase NA Completed
Clinical Trials
11 trialsNCT06831994 2025-06-29
Digital Implementation of the German S3 Clinical Practice Guideline for Multimorbidity
Universitätsklinikum Hamburg-Eppendorf
Phase NA Recruiting
NCT06061172 2024-12-12
gp-multitool
Universitätsklinikum Hamburg-Eppendorf
Phase NA Completed
NCT06080542 2023-10-19
TAILOR/1b
University of Valencia
Phase NA Completed
NCT05308095 2022-12-21
The HEADWIND Study - Part 4
Insel Gruppe AG, University Hospital Bern
Phase NA Completed
NCT04729296 2021-12-02
Anti-TNFα to Delay or Prevent Progression to Stage 3 T1D
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase 2 Withdrawn
NCT04942756 2021-07-22
GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Glucose Monitoring (CGM) by Using FreeStyle Libre 2 (FSL2) for Preventing Hyperglycemia/Hypoglycemia Crisis in Advanced Oncological Patients.
Antea Foundation
Phase NA Unknown
NCT04569630 2021-06-29
HEADWIND
Insel Gruppe AG, University Hospital Bern
Phase NA Completed
NCT00566813 2021-04-06
Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression
University of Illinois at Chicago
Phase 1/2 Completed
NCT04100070 2020-12-04
DEEP
ISIS Diabete Service
Phase NA Unknown
NCT02000817 2019-06-24
Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients
GlaxoSmithKline
Phase 1/2 Completed